Asthma Clinical Trial
Official title:
Comprehension and Evaluation of a Pictorial Action Plan for Those With Asthma or Chronic Obstructive Pulmonary Disease
Some five million people in the United Kingdom (U.K.) have asthma. The British Guidelines on
Asthma recommend self management education and the issuing of written personal asthma action
plans. The use of such self management education has been shown to be associated with an up
to 40% reduction in hospitalisation rates and a 20% reduction in Emergency Department
attendances and similar benefits in terms of symptoms and time off work. In asthma, the
results are best when the patients are provided with a personalised written action plan
explaining how to alter their medications according to a variety of circumstances. Chronic
obstructive pulmonary disease is a major cause of hospitalisation in the U.K. and is the
fourth biggest single cause of death. A recent Cochrane review regarding the value of self
management education in COPD has led to equivocal results although it has shown that those
with COPD are willing to take control of their own conditions. The reasons for the different
outcomes in asthma and COPD may reflect an inadequate number of trials of the wrong type;
interventions that were not appropriate or do not work; lack of the use of written action
plans; or assessment of benefit using the wrong outcomes.
Given the importance attached to the written action plan, it is essential that such advice is
available to all. However, studies of outpatients attending hospitals in the U.K. have shown
that 15% may be functionally illiterate and in studies of adults with asthma in the United
States (U.S.), 13% have similarly shown to be functionally illiterate. Pictorial advice may
therefore be advantageous and, when tested amongst those who are literate, it has been also
shown to enhance the recall of spoken medical instructions. The investigators have therefore
prepared some pictorial representations which are designed to give advice to those with
asthma and COPD about how to recognise the worsening of their conditions and what treatments
to alter or initiate as a result. The investigators now need to assess the comprehensibility
of those materials amongst a selection of patients with asthma and COPD.
Some five million people in the U.K have asthma. The British Guidelines on Asthma recommend
self management education and the issuing of written personal asthma action plans. The use of
such self management education has been shown to be associated with an up to 40% reduction in
hospitalisation rates and a 20% reduction in Emergency Department attendances and similar
benefits in terms of symptoms and time off work. In asthma, the results are best when the
patients are provided with a personalised written action plan explaining how to alter their
medications according to a variety of circumstances. Chronic obstructive pulmonary disease is
a major cause of hospitalisation in the U.K. and is the fourth biggest single cause of death.
A recent Cochrane review regarding the value of self management education in COPD has led to
equivocal results although it has shown that those with COPD are willing to take control of
their own conditions. The reasons for different outcomes in asthma and COPD may reflect an
inadequate number of trials of the wrong type; interventions that were not appropriate or do
not work; lack of the use of written action plans; or assessment of benefit using the wrong
outcomes.
Given the importance attached to the written action plan, it is essential that such advice is
available to all. However studies of outpatients attending hospitals in the U.K. have shown
that 15% may be functionally illiterate and in studies of adults with asthma in the U.S., 13%
have similarly shown to be functionally illiterate. Pictorial advice may therefore be
advantageous and when tested amongst those who are literate, it has been also shown to
enhance the recall of spoken medical instructions. The investigators have therefore prepared
some pictorial representations which are designed to give advice to those with asthma and
COPD about how to recognise the worsening of their conditions and what treatments to alter or
initiate as a result. The investigators now need to assess the comprehensibility of those
materials amongst a selection of patients with asthma and COPD.
Patients will be recruited from two clinics (asthma and COPD) on a Tuesday morning and
Thursday afternoon.
On arrival to the Asthma clinic and to the COPD clinic, patients will be given a short
information leaflet which they will be invited to read whilst waiting to see the doctor. At
the end of the routine consultation they will be asked if they would be willing to help with
the study and will be given a patient information sheet and if the patient agrees he/she,
will be asked to sign the consent form. The voluntary nature of this and the fact that
non-participation will not in any way influence their routine care would be stressed
repetitively, both verbally and of course in the patient information leaflet. If the patients
were willing to spend a few minutes with the researcher, they would be introduced to the
researcher by the consultant in clinic and the interview would either occur on that occasion
or at a pre-arranged time to suit the patient. In the first part of the interview, the
patient would be given the two pictorial questionnaires to complete which assess the
translucency and guessability of the pictogram used for the investigators' pictorial action
plans. The second part of the interview would involve explaining to the patient the concept
of self management education and personal action plans and a pictorial action plan relevant
to the patient would be shown to the patient and he/she would be asked to describe what
action should be taken as a result of the pictorial sequences. A series of short questions
about the self management plan and his/her preferences for either written or a pictorial plan
would be asked. The patient would also be asked to undertake the REALM adult literacy test
and demographic data regarding educational attainment, age and ethnicity would also be
recorded.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|